Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160

Abstract

THE development of a vaccine to provide protective immunity to human immunodeficiency virus type 1 (HIV-1), the virus causing AIDS, would be the most practical method to control its spread. Subunit vaccines consisting of virus envelope glycoproteins, produced by recombinant DNA technology, are effective in preventing viral infections1. We have now used this approach in the development of a candidate AIDS vaccine. Chimpanzees were immunized with recombinant forms of the HIV-1 glycoproteins gp120 and gp160 produced in Chinese hamster ovary cells, and then challenged with HIV-1. The control and the two animals immunized with the gp160 variant became infected within 7 weeks of challenge. The two animals immunized with the gp120 variant have shown no signs of infection after more than 6 months. These studies demonstrate that recombinant gp120, formulated in an adjuvant approved for human use, can elicit protective immunity against a homologous strain of HIV-1.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Scolnick, E. M. et al. J. Am. med. Assoc. 251, 2812–2815 (1984).

    CAS  Article  Google Scholar 

  2. 2

    Lasky, L. A. et al. Science 233, 209–21 (1986).

    ADS  CAS  Article  Google Scholar 

  3. 3

    Berman, P. W. et al. J. Virol. 63, 3489–3498 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. 4

    Lasky, L. A. et al. Cell 50, 975–985 (1987).

    CAS  Article  Google Scholar 

  5. 5

    Leonard, C. K. et al. J. biol. Chem. (in the press).

  6. 6

    Berman, P. W., Gregory, T., Crase, D. & Lasky, L. A. Science 277, 1490–1492 (1985).

    ADS  Article  Google Scholar 

  7. 7

    Berman, P. W. et al. Proc. natn. Acad. Sci. U.S.A. 85, 5200–5204 (1988).

    ADS  CAS  Article  Google Scholar 

  8. 8

    Anderson, K. P. et al. J. infect. Diseases 160, 960–969 (1989).

    CAS  Article  Google Scholar 

  9. 9

    Robertson, G. A., Kostek, B. M., Schleif, W. A., Lewis, J. A. & Emini, E. A. J. virol. Meth. 20, 195–202 (1988).

    CAS  Article  Google Scholar 

  10. 10

    Arthur, L. O. J. Virol. 63, 5046–5053 (1989).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. 11

    Prince, A. M. et al. Proc. natn. Acad. Sci. U.S.A. 85, 6944–6948 (1988).

    ADS  CAS  Article  Google Scholar 

  12. 12

    Emini, E. A. et al. J. Virol. (in the press).

  13. 13

    Kellog, D. E. & Kwok, S. in PCR Protocols (ed. Innis, M. A., Gelfand, D. H., Sninsky, J. J. & White, J.) 337–347 (Academic, New York, 1990).

    Google Scholar 

  14. 14

    Rusche, J. R. et al. Proc. natn. Acad. Sci. U.S.A. 85, 3198–3202 (1988).

    ADS  CAS  Article  Google Scholar 

  15. 15

    Massey, R. J. & Schochetman, G. Science 213, 447–449 (1981).

    ADS  CAS  Article  Google Scholar 

  16. 16

    Homsy, J., Meyer, Mia, Tateno, M., Clarkson, S. & Levy, J. A. Science 244, 1357–1359 (1989).

    ADS  CAS  Article  Google Scholar 

  17. 17

    Robinson, E. W. Jr, Montefiori, D. C. & Mitchell, W. M. Lancet i, 790–794 (1988).

    Article  Google Scholar 

  18. 18

    Robinson, E. W. Jr et al. Proc. natn. Acad. Sci. U.S.A. 87, 3185–3189 (1990).

    ADS  CAS  Article  Google Scholar 

  19. 19

    Germain, R. N. Nature 322, 687–689 (1986).

    ADS  CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Berman, P., Gregory, T., Riddle, L. et al. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 345, 622–625 (1990). https://doi.org/10.1038/345622a0

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing